Explore more publications!
Mongolia Healthcare Journal
Got News to Share?

Mongolia Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mongolia Healthcare Journal.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on December 30, 2025

InnovAge Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference
Dec. 30, 2025

InnovAge Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)
Dec. 30, 2025

The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)

Indeterminate GlobeNewswire
The 2025 Brain Health Breakthrough of the Year
Dec. 30, 2025

The 2025 Brain Health Breakthrough of the Year

Indeterminate GlobeNewswire
Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
Dec. 30, 2025

Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

Indeterminate GlobeNewswire
Prenetics Announces Update to Capital Allocation Strategy; Ceases Bitcoin Purchases to Focus on IM8
Dec. 30, 2025

Prenetics Announces Update to Capital Allocation Strategy; Ceases Bitcoin Purchases to Focus on IM8

Indeterminate GlobeNewswire
Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in NonAdvanced Systemic Mastocytosis
Dec. 30, 2025

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in NonAdvanced Systemic Mastocytosis

Indeterminate GlobeNewswire
XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
Dec. 30, 2025

XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

Indeterminate GlobeNewswire
InflaRx Provides Update on Phase 3 Data Analyses for Vilobelimab in Pyoderma Gangrenosum
Dec. 30, 2025

InflaRx Provides Update on Phase 3 Data Analyses for Vilobelimab in Pyoderma Gangrenosum

Indeterminate GlobeNewswire
EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital
Dec. 30, 2025

EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital

Indeterminate GlobeNewswire
Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
Dec. 30, 2025

Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Savolitinib for the treatment of Gastric Cancer Patients with MET Amplification
Dec. 30, 2025

HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Savolitinib for the treatment of Gastric Cancer Patients with MET Amplification

Indeterminate GlobeNewswire
Best Zepbound Alternative for 2026? FDA Regulatory Timeline Reshapes Telehealth Tirzepatide Access as SkinnyRx Platform Lists Compounded Options
Dec. 30, 2025

Best Zepbound Alternative for 2026? FDA Regulatory Timeline Reshapes Telehealth Tirzepatide Access as SkinnyRx Platform Lists Compounded Options

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions